Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke


Phase 3 Results

Summary of Purpose

The study design is subject to relevant SFDA regulations about clinical trials. This indication was approved in Japan in 2003. From the end of May 2004 to the end of Dec. 2004, 720 patients with previous cerebral infarction(see the inclusion criteria) were enrolled in to the study and received one of the two treatment regimens, Cilostazol or Aspirin, the ratio of patient number of each group is 1:1. For...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 March 2006.

1 May 2004 12 Sep 2005 Unavailable 1 Jan 2006 1 Mar 2006 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available